Neola Medical is in the process of establishing itself properly in the US to gear up its work with the Neola® lung monitoring system. The company is now carrying out a directed share issue of 20 million SEK to finance the development and market preparations. BioStock reached out to CEO Hanna Sjöström to find out more.

Read the article here: BioStock – Premium in Neola Medicals directed issue

Read the press release here: Press release – Neola Medical carries out a directed share issue of 20 MSEK and thereby secures financing for 2024